Chosa Oncology Exercises Warrants, Raises SEK 2.8 Million
Chosa Oncology AB announced the results of its warrant series TO 2 exercise. Approximately 45 percent of the warrants were exercised, raising SEK 2.8 million before costs.
Chosa Oncology AB has reported the outcome of its warrant series TO 2 exercise. The company announced that a total of 3,577,285 warrants were exercised for the subscription of new shares.
This exercise rate represents approximately 45 percent of the total number of warrants issued. Through this exercise, Chosa Oncology will receive approximately SEK 2.8 million before transaction costs.
The warrants were initially issued as part of the company's unit offering in the second quarter of 2025. Further details regarding specific terms and other company announcements can be found through the company's official communication channels.